Major breakthrough in battle for HIV cure ‘previously thought impossible'
Scientists have found a breakthrough in the search for a cure for HIV, after research uncovered a development 'previously thought impossible'.
HIV can 'hide' itself in white blood cells, meaning the immune system and treatment drugs are unable to find and tackle them.
However, researchers at the Peter Doherty Institute for Infection and Immunity in Melbourne have now found a way to force the virus out of some human cells it was hiding within.
This could potentially allow the immune system or drugs to identify the virus and clear it, meaning researchers are one step closer to a cure.
Dr Paula Cevaal, research fellow at the Doherty Institute and co-first author of the study published in Nature Communications, told The Guardian that delivering mRNA to the cells was 'previously thought impossible', as they did not take up the LNPs used to carry it.
But the team then developed a new type of lipid nanoparticles (LNP), which allowed mRNA technology to be delivered to the blood cells. The mRNA then instructs the cells to reveal the virus.
She told the paper that the team initially thought the results were 'too good to be true', adding that they hoped the new nanoparticle design could be a 'new pathway to an HIV cure'.
'We sent her back into the lab to repeat it, and she came back the next week with results that were equally good,' she said.
'So we had to believe it. And of course, since then, we've repeated it many, many, many more times.
'We were overwhelmed by how [much of a] night and day difference it was – from not working before, and then all of a sudden it was working. And all of us were just sitting gasping like, 'wow'.'
She added: 'In the field of biomedicine, many things eventually don't make it into the clinic – that is the unfortunate truth; I don't want to paint a prettier picture than what is the reality,
'But in terms of specifically the field of HIV cure, we have never seen anything close to as good as what we are seeing, in terms of how well we are able to reveal this virus.
'So from that point of view, we're very hopeful that we are also able to see this type of response in an animal, and that we could eventually do this in humans.'
The study was done using cells donated by HIV patients. More research will now have to be done to see if the steps taken to reveal the virus will result in the body's immune system will be able to tackle it.
It will likely take years of further safety testing before the new discovery could be used in human trials.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
28 minutes ago
- Daily Mail
Major HIV breakthrough forces hidden fragments of the virus to emerge so it can be cleared from the body
Experts could have found a way to be one step closer to curing HIV for good. Researchers in Australia has developed a new treatment that forces hidden fragments of the virus - normally concealed within human cells - to emerge and expose themselves to the immune system. The breakthrough could enable the body, aided by antiviral drugs, to detect and destroy any lingering viral reservoirs. HIV has remained incurable because the virus can integrate itself into a cell's DNA, laying dormant and undetectable to both medication and immune defenses. Scientists said they've created a nanoparticle capable of delivering genetic instructions to infected cells, prompting them to produce a signal that reveals the virus's presence. Dr Paula Cevaal of the Doherty Institute and co-author of the study told The Guardian that the feat was 'previously thought impossible'. Cevaal said: 'In the field of biomedicine, many things eventually don't make it into the clinic, that is the unfortunate truth; I don't want to paint a prettier picture than what is the reality. 'But in terms of specifically the field of HIV cure, we have never seen anything close to as good as what we are seeing, in terms of how well we are able to reveal this virus. 'So, from that point of view, we're very hopeful that we are also able to see this type of response in an animal, and that we could eventually do this in humans.' The discovery was first revealed in the journal Nature Communications, where researchers said they were initially so astonished that they had to rerun the tests. Further research would be needed to determine whether revealing the virus would be enough to trigger an immune response, with tests only being carried out in the lab. It could still take years before clinical trials for the drug began, when it would have to go through rigorous testing before reaching consumers. However, the advance represents another step forward for the 1.2 million Americans currently living with an HIV infection - for which they took drugs daily. An estimated 31,800 people were believed to be infected every year, although that's a 12 per cent decline on five years ago. Globally, nearly 40 million people have the virus. The new nanoparticle's based on mRNA technology, the same as was used in covid vaccines made by Pfizer and other vaccine manufacturers. In their paper, the scientists revealed that they could deliver mRNA instructions to cells using the nanoparticle. The mRNA then instruct cells to generate substances that reveal the presence of HIV, but only if the virus was present. The study done in the laboratory was carried out in cells donated by HIV patients.
Medical News Today
an hour ago
- Medical News Today
Psilocybin for IBS: Could altering the mind help alter the gut?
Could magic mushrooms help relieve symptoms and treat IBS? A new study aims to find out. Irina Efremova/Stocksy Irritable bowel syndrome (IBS) is one of the most common conditions affecting the gut. Despite its prevalence and decades of research, treatments are limited, and the underlying causes remain shrouded in mystery. An ongoing study, conducted by Erin Mauney, MD, is taking a fascinating new approach to this mysterious condition: psychedelics, and more specifically psilocybin. In this article, we will investigate why researcher Erin Mauney believes psilocybin — the active compound in magic mushrooms — might help treat irritable bowel syndrome (IBS), and how her ongoing research is breaking new ground. To help us understand how altering the mind might alter the gut, we will first explore the links between body and brain. Historically — and, to a certain extent, still today — the mind and body have been considered separate. As science has progressed, it has become increasingly clear that, of course, the mind is part of the body. There is no separation. The brain is in tight communication with the body at all times via nerves and chemicals, like hormones and neurotransmitters, and the body talks back in the same language. This two-way interaction is perhaps most pronounced between the brain and the gut. The enteric nervous system (the nervous system of the gut) is the second-largest nervous system in the body after the brain. Some experts even refer to the gut as our 'second brain.' Although the enteric nervous system evolved first, so we could consider it the ' first brain .' Aside from their shared ancient pedigree, why would the gut and brain share such a tight link? In our modern world, where we are never more than 20 meters from a bagel, it is easy to forget that life on the Savannah millennia ago was much less convenient. The gut needed to tell the brain when it required refilling with enough time to hunt, scavenge, or forage for its next meal. As the food is ingested, the brain needs to ask the gut to ramp up its operations and prepare to digest. This relationship helps explain why we can feel longing in the pit of our stomach, and butterflies dance in our intestines when we feel excited: The gut and brain are in cahoots. Speaking in a recent interview, published in the journal Psychedelics , Mauney explains how, during her gastroenterology training, she 'became aware of how common trauma, especially early life trauma, is in the human experience.' 'Although there is more discussion in pediatrics about the cumulative effects of toxic stress over the lifespan,' she continues, 'I think overall this is an area that medicine, particularly gastroenterology and obesity medicine, really fails to understand and address meaningfully.' This piqued her interest in psychological approaches to gut issues. These links have led researchers to believe that IBS has a strong gut-brain component. Mauney and colleagues are currently embarking on the first-ever study to investigate whether talking therapy in conjunction with psilocybin might help relieve symptoms of IBS. Speaking in an interview with the Journal of Clinical Gastroenterology ( JC G), Mauney explained that around 60% of people with IBS do not respond to first-line therapies, such as dietary interventions or medications. So, the scientists recruited people with IBS who had already tried a wide range of approaches without experiencing significant benefits. This, she explains, included talking therapies, mind-body therapies, dietary changes, and drugs. In her JC G interview, Mauney explains how psilocybin acts 'transdiagnostically.' In other words, it can alter a range of psychological domains that are common across multiple mental health conditions. For instance, she explains how the drug can influence psychological characteristics such as: Rigidity: An inability to adapt or change. An inability to adapt or change. Rumination: Dwelling on negative thoughts and feelings. Dwelling on negative thoughts and feelings. Anxious over-focus on the self: A preoccupation with personal matters, while almost forgetting the outside world. She also says that psychedelics like psilocybin can help some people shift ingrained thought patterns, which is another facet of many mental health conditions, and some people with IBS. Beyond the psychological aspects of psilocybin treatment, Mauney also has some gut-focused theories. As the gut digests food, it squeezes, swells, deflates, and so on. For most people, these movements cause no distress or go unnoticed. For people with IBS, however, these routine movements may cause discomfort or pain. This is called visceral hypersensitivity. Research in animals suggests that a subtype of serotonin receptors in the gut, called 5HT2a receptors, might play a role in visceral hypersensitivity. Why does this matter? Psilocybin primarily works by activating 5HT2a receptors — so, perhaps it might reduce these uncomfortable sensations. Aside from this link, as Mauney explains in her JCG interview, scientists have also explored whether psilocybin might reduce pain in general. For instance, researchers have examined, with differing results, whether psilocybin could help in the treatment of migraine headaches, chronic neuropathic pain, fibromyalgia, and more. Because IBS causes visceral pain, this is yet another potential mechanism by which it may impart benefits. With its potential to influence psychology, visceral hypersensitivity, pain, and inflammation, psilocybin is a hopeful candidate for the treatment of IBS. Now, we just need to see the data. Mauney and colleagues' ongoing study was halfway through enrollment as of her April 24th JC G interview. Although she was cautious not to preempt the findings, Mauney was excited to share that at least some of the participants had experienced benefits. In the study, participants are paired with two medical professionals with backgrounds in psychotherapy or psychiatry. Each of the two therapy sessions (two weeks apart) involves the 'dosing' part of the study, where the participant takes psilocybin and relaxes while listening to a carefully curated playlist. Then, the three of them discuss the participants' symptoms, previous life experiences, and whatever comes up during the session. In total, these sessions last 6–8 hours. Mauney explains how the psilocybin 'acts as an amplifier of therapeutic processes,' perhaps enhancing standard talking therapy. Although this approach has not worked for everyone in the trial, for some, Mauney says, it has. She explains that it has encouraged some individuals to engage deeply with difficult parts of their lives, make meaningful changes that they could not manage before, or influence close relationships in ways that have led to reduced symptoms. For others, their symptoms have remained unchanged, but they report that the symptoms are no longer so bothersome. Medical News Today reached out to Ruvini Wijetilaka, MD, a board certified Internal Medicine Physician at Mecca Health, who was not involved in the study. 'As a physician, I find this early research into psilocybin-assisted therapy for treatment-resistant IBS intriguing and encouraging,' she explained. 'IBS is a complex condition rooted in the brain-gut connection,' she continued, 'and traditional treatments don't always work for everyone.' 'In cases where symptoms persist despite initial interventions, psilocybin may offer a promising alternative for targeting the neurological pathways involved. It's an exciting area of exploration for patients who experience chronic, unrelenting symptoms and have few remaining options.' — Ruvini Wijetilaka, MD Mauney's study is the first to look at this relationship, and the preliminary results are encouraging. However, as she explains, the study is not yet complete, and it might not work. With that said, because the mechanistic theory is promising, and it seems that at least some people have already benefited, we might be forgiven for being optimistic. 'It might sound a little bit out there to the average gastroenterologist,' says Mauney. 'But I think this is really what's needed, and what our patients are calling out for. […] A holistic approach to their suffering.' 'People with IBS that are not responding to available treatments need more options. Under the right conditions, psychedelics are worth a try for this group,' he said. However, he also suggested comparing its efficacy with Emotional Awareness and Expression Therapy (EAET), which he told us has had some success in the treatment of 'people with chronic musculoskeletal pain, back pain (when combined with mindfulness), and long COVID.' Psilocybin is unlikely to work for everyone, but Mauney hopes that, at least for some, this intervention could improve thought processes and relieve the negative impact of a chronic condition that remains poorly understood. 'While more concrete research is needed on this, the study could mark a meaningful shift in how we approach IBS care and gut health as a whole,' concluded Wijetilaka.
Scotsman
an hour ago
- Scotsman
warning signs of Victorian era STI
There is concern after the latest data showed cases of syphilis had continued to rise 🏥 Sign up to our daily newsletter – Regular news stories and round-ups from around Scotland direct to your inbox Sign up Thank you for signing up! Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... The UK Health and Security Agency (UKHSA) has published its latest data on sexually transmitted infections (STI). Concerningly cases of syphilis, an STI most commonly associated with the Victorian era have continued to rise. If left untreated, syphilis can cause serious and potentially life-threatening complications. Cases of a Victorian era sexually transmitted infection (STI), are continuing to increase, latest data from the UKHSA has shown. Syphilis, is an STI that was once believed to be a thing of the past, however, cases are 'concerningly' on the rise in 2024, compared to 2023. Advertisement Hide Ad Advertisement Hide Ad Overall, there was a 2% rise (9,535) in diagnoses of early-stage syphilis in 2024 compared to 2023 (9,375), whilst 'concerningly', figures rose to 5% for late-stage syphilis, increasing from 12,456 in 2023 to 13,030 in 2024. If left untreated, syphilis can cause serious, irreversible and potentially life-threatening problems with your brain, heart, or nerves. Dr Hamish Mohammed, Consultant Epidemiologist at UKHSA, said: 'Levels of STIs in this country remain a big threat to sexual wellbeing. These infections can have a major impact on your health and that of any sexual partners, particularly if they are antibiotic resistant. 'If you've had condomless sex with new or casual partners, either in the UK or overseas, get tested for STIs and HIV at least yearly, even if you don't have symptoms. Regular testing protects both you and those you're having sex with.' Advertisement Hide Ad Advertisement Hide Ad New data from the UK Health Security Agency (UKHSA) shows that syphilis cases have continued to rise. |What is syphilis? Syphilis is a sexually transmitted infection (STI), that is passed on through unprotected sexual contact. Most commonly associated with the Victorian era, it is still prevalent, with cases 'concerningly', continue to rise in the UK. What are the symptoms of syphilis? Symptoms of syphilis can take up to three weeks to appear after being infected. They can be mild and come and go, but the infection will remain and you will be able to pass it on. This is why if you suspect you have syphilis or have symptoms it's important to get tested. The NHS explain symptoms of syphilis include: small sores (ulcers) on your penis, vagina, or around your bottom (anus) sores in other areas, including in your mouth or on your lips, hands or bottom white or grey warty growths most commonly on your penis, vagina or around your anus a rash on the palms of your hands and soles of your feet that can sometimes spread all over your body white patches in your mouth flu-like symptoms, such as a high temperature, headaches and tiredness swollen glands patchy hair loss on the head, beard and eyebrows Who is at risk of syphilis? You are at risk of syphilis if you have unprotected sexual contact (vaginal, anal or oral), with someone who is infected with syphilis. Advertisement Hide Ad Advertisement Hide Ad The STI can also be passed onto unborn babies or can spread through injecting drugs with a needle that has been used by someone who is infected, in very rare cases it can also be passed on through blood or organ transplants, although in the UK all blood and organ donations are checked for syphilis. How is syphilis treated? Syphilis is treated with antibiotics, it's important not to engage in sexual contact until you have completed your treatment and had a test that has confirmed you are over the infection. If you have a partner, do not have sexual contact until they have also been treated and a test has confirmed they no longer have syphilis. If left untreated, syphilis can cause serious, irreversible and potentially life-threatening problems with your brain, heart, or nerves. This is why it's so important to seek treatment as soon as you suspect you have been exposed or have symptoms.
